Small Lymphocytic Lymphoma
Showing NaN - NaN of 24
Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Anemia
- +2 more
- Cyclophosphamide
- +6 more
-
Birmingham, Alabama
- +795 more
Jan 28, 2023
SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- Electronic Health Record Review
-
Duarte, California
- +10 more
Jan 12, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
- Acalabrutinib
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 19, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Venetoclax
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Dec 5, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Boston, Massachusetts
- +11 more
Nov 23, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma
-
Boston, Massachusetts
- +2 more
Mar 16, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- +6 more
-
Duarte, California
- +165 more
Mar 24, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
La Jolla, California
- +91 more
Dec 14, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Little Rock, Arkansas
- +144 more
Dec 3, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Acalabrutinib)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Venetoclax
- +2 more
-
Boston, Massachusetts
- +2 more
Aug 9, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- IPI-145 (duvelisib)
- Ofatumumab
-
La Jolla, California
- +68 more
Mar 15, 2021
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ofatumumab, ibrutinib)
Completed
- Relapsed or Refractory Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
La Jolla, California
- +75 more
Dec 3, 2019
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (TG02 citrate)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- TG02 citrate
-
Augusta, Georgia
- +4 more
Jul 23, 2019
Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),
Completed
- Acute Leukemia
- +8 more
- Tacrolimus (ARM with Methotrexate)
- +7 more
-
Duarte, California
- +29 more
Jan 2, 2019
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston, Lebanon (Bendamustine, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Boston, Massachusetts
- +1 more
Mar 28, 2018
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B Chronic Lymphocytic Leukemia Trial in Boston (Lenalidomide,
Completed
- Chronic Lymphocytic Leukemia
- +2 more
- Lenalidomide
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2018
Follicular Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma Trial in Boston (ofatumumab)
Completed
- Follicular Lymphoma
- +2 more
-
Boston, Massachusetts
- +2 more
Sep 18, 2017
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (dasatinib, Rituximab, fludarabine)
Terminated
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- dasatinib
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 17, 2017
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Duvelisib, Venetoclax)
Withdrawn
- Chronic Lymphocytic Leukemia
- +2 more
-
Tucson, Arizona
- +9 more
Jul 22, 2016
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (PCI-32765)
Completed
- B-cell Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Boston, Massachusetts
- +5 more
Jul 17, 2014